ERC Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Endocrine-Related Cancer 5 (4) 283-291    DOI: 10.1677/erc.0.0050283
Copyright © 1998 by the Society for Endocrinology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langdon, S P
Right arrow Articles by Smyth, J F
Right arrow Search for Related Content
PubMed
Right arrow Articles by Langdon, S P
Right arrow Articles by Smyth, J F

Growth factors and ovarian cancer

S P Langdon 1 and J F Smyth 1

1 ICRF Medical Oncology Unit, Western General Hospital, Edinburgh, EH4 2XU, UK

Ovarian cancer is the most common cause of death from gynaecological malignancy developing in about 1 women in 70 and killing 1 in 100. Annually, it accounts for about 5000 new cases in the UK and 24 000 in the USA, with approximately 3500 and 13 500 deaths respectively in the same period. The growth and progression of this disease is driven by a variety of regulators including growth factors, hormones and cytokines.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society for Endocrinology.